Attached files
| file | filename |
|---|---|
| S-1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v170098_s1.htm |
| EX-5.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v170098_ex5-1.htm |
| EX-24.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v170098_ex24-1.htm |
| EX-21.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v170098_ex21-1.htm |
Exhibit
23.1
Consent of Independent
Registered Public Accounting Firm
Neoprobe
Corporation
Dublin,
Ohio
We hereby
consent to the use in the Prospectus constituting a part of this Registration
Statement of our report dated March 27, 2009, except for Note 2 which is as of
December 22, 2009, relating to the consolidated financial statements of Neoprobe
Corporation which is contained in that Prospectus.
We also
consent to the reference to us under the caption “Experts” in the
Prospectus.
|
/s/
BDO Seidman, LLP
|
Chicago,
Illinois
December
28, 2009